Detection of Viral Particels in Urticaria Patients

Urticaria Chronic Clinical Trial

Official title:
Detection of Viral Particels in Urticaria Patients

Status Recruiting

Clinical Trial Summary

Blood samples from urticaria patients will be analyzed for viral particles

Clinical Trial Description

After digestion with DNase to eliminate human DNA, RNA will be reversed-transcribed and amplified with random primer/ Amplification products will be pooled and sequenced/ After substruction of sequences of vertebrates and highly repetitive sequences, contiguous sequences will be assembled and compared with motifs represented in databases of viruses. which will enable identification of putative protein sequences consistent with viruses ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03151902
Study type	Observational
Source	HaEmek Medical Center, Israel
Contact	Menachem Rottem, MD
Phone	+972-528617823
Email	rottem_me@clalit.org.il
Status	Recruiting
Phase
Start date	July 2, 2017
Completion date	September 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03111628` - Role of Immunoglobulin E (IgE) Bearing Cells in Chronic Idiopathic Urticaria (CIU)	Phase 4
Completed	`NCT03632291` - Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU Patients	Phase 1
Completed	`NCT05461456` - Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%	Phase 1